PVR and breast carcinoma: mRIPO-infected PECs exerted antitumor effects after co-implantation with wild type (wt, non-permissive to mRIPO) B16 melanoma or E0771 breast cancer cells in CD155-tg mice (Fig. 2b; Supplementary Fig. 5b).